International Biotechnology Trust as of June 30, 2017
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 60 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | 9.0 | $24M | 48k | 491.15 | |
| Celgene Corporation | 8.8 | $23M | 178k | 129.86 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.6 | $18M | 136k | 128.87 | |
| Biogen Idec (BIIB) | 6.3 | $17M | 61k | 271.27 | |
| Alexion Pharmaceuticals | 4.5 | $12M | 97k | 121.67 | |
| BioMarin Pharmaceutical (BMRN) | 4.1 | $11M | 118k | 90.82 | |
| Incyte Corporation (INCY) | 3.7 | $9.8M | 78k | 125.91 | |
| Amgen (AMGN) | 3.3 | $8.6M | 50k | 172.22 | |
| Gilead Sciences (GILD) | 3.3 | $8.6M | 122k | 70.77 | |
| Entellus Medical Cm | 2.1 | $5.7M | 342k | 16.56 | |
| Mylan Nv | 2.1 | $5.4M | 140k | 38.81 | |
| Shire | 2.0 | $5.4M | 33k | 165.26 | |
| Acceleron Pharma | 2.0 | $5.4M | 178k | 30.38 | |
| Radius Health | 2.0 | $5.2M | 115k | 45.24 | |
| Exelixis (EXEL) | 1.9 | $5.1M | 207k | 24.62 | |
| Neuroderm Ltd F | 1.9 | $5.0M | 168k | 29.80 | |
| Aerie Pharmaceuticals | 1.9 | $4.9M | 94k | 52.50 | |
| Tesaro | 1.8 | $4.7M | 34k | 139.85 | |
| Portola Pharmaceuticals | 1.6 | $4.3M | 76k | 56.17 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $4.2M | 27k | 155.52 | |
| D Stemline Therapeutics | 1.6 | $4.2M | 453k | 9.20 | |
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $3.8M | 138k | 27.89 | |
| Dermira | 1.4 | $3.8M | 129k | 29.12 | |
| Calithera Biosciences | 1.4 | $3.6M | 244k | 14.85 | |
| Synergy Pharmaceuticals | 1.3 | $3.4M | 772k | 4.44 | |
| Seattle Genetics | 1.3 | $3.4M | 65k | 51.74 | |
| Achaogen | 1.3 | $3.4M | 155k | 21.73 | |
| Clovis Oncology | 1.2 | $3.3M | 35k | 93.60 | |
| Adamas Pharmaceuticals | 1.2 | $3.2M | 185k | 17.47 | |
| United Therapeutics Corp Del | 1.1 | $2.8M | 22k | 129.72 | |
| Array BioPharma | 1.0 | $2.7M | 321k | 8.36 | |
| Halozyme Therapeutics (HALO) | 1.0 | $2.6M | 205k | 12.81 | |
| Ionis Pharmaceuticals (IONS) | 1.0 | $2.6M | 52k | 50.87 | |
| Illumina (ILMN) | 0.9 | $2.4M | 14k | 173.52 | |
| Kite Pharma | 0.9 | $2.3M | 22k | 103.67 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $2.3M | 322k | 7.06 | |
| Prothena (PRTA) | 0.9 | $2.3M | 42k | 54.14 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $2.1M | 61k | 33.70 | |
| Horizon Pharma | 0.8 | $2.0M | 169k | 11.86 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $1.9M | 37k | 51.46 | |
| Foamix Pharmaceuticals | 0.6 | $1.7M | 359k | 4.64 | |
| Veracyte (VCYT) | 0.5 | $1.4M | 170k | 8.32 | |
| Paratek Pharmaceuticals | 0.5 | $1.4M | 58k | 24.05 | |
| Intercept Pharmaceuticals In | 0.5 | $1.4M | 11k | 121.11 | |
| Sage Therapeutics (SAGE) | 0.5 | $1.4M | 17k | 79.61 | |
| Five Prime Therapeutics | 0.5 | $1.2M | 41k | 30.12 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $1.1M | 59k | 18.86 | |
| Ligand Pharmaceuticals In (LGND) | 0.4 | $1.1M | 9.0k | 121.44 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $1.0M | 63k | 16.25 | |
| Merus N V (MRUS) | 0.4 | $966k | 61k | 15.85 | |
| Macrogenics (MGNX) | 0.4 | $945k | 54k | 17.50 | |
| Gw Pharmaceuticals Plc ads | 0.3 | $922k | 9.2k | 100.22 | |
| Supernus Pharmaceuticals (SUPN) | 0.3 | $902k | 21k | 43.05 | |
| Pacira Pharmaceuticals (PCRX) | 0.3 | $762k | 16k | 47.62 | |
| Pieris Pharmaceuticals (PIRS) | 0.3 | $712k | 141k | 5.05 | |
| Trillium Therapeutics, Inc. Cmn | 0.3 | $693k | 161k | 4.30 | |
| Transenterix | 0.2 | $622k | 889k | 0.70 | |
| Omeros Corporation (OMER) | 0.2 | $602k | 30k | 19.91 | |
| Global Blood Therapeutics In | 0.2 | $561k | 21k | 27.37 | |
| Xencor (XNCR) | 0.1 | $380k | 18k | 21.11 |
